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Abstract—MoSHCA is a mHealth project designed to improve
patient-doctor interaction and to promote the self-management
of chronic diseases by the patients themselves. The number
of people with a chronic disease is dramatically increasing
worldwide. This is becoming a major obstacle for economic
stability and growth and the sustainability of national health care
systems. The introduction of self-management by patients with
a chronic disease seems inevitable as a countermeasure against
these developments. MoSHCA provides intelligent, user-friendly
and secure, medical and well-being decision support through
embedded software in mobile devices by utilizing specific sensors
and data from customized information systems.
I. INTRODUCTION
The World Health Organization (WHO) forecasts that the
number of people aged over 60 will soon reach 2 billion. This
ageing trend is fueling a dramatic increase in the prevalence
of disability and chronic illnesses, with enormous impact not
only on individuals but also on the countries’ health care
systems and economies [1], [2]. There is an urgent need
for taking actions to reduce the increasing prevalence of
chronic diseases and to introduce cost-effective prevention and
treatment strategies to reverse this trend. Typical examples
of such chronic diseases are chronic obstructive pulmonary
disease (COPD) and diabetes mellitus type 2.
According to the European Lung White Book, COPD is
one of the few leading causes of death that are increasing
in prevalence worldwide [3]. The WHO Global Burden of
Disease Study has projected COPD mortality rates from 1990–
2020 and estimates that COPD will account for over 6 million
deaths per year in 2020, which will move COPD from the sixth
to the third leading cause of death worldwide over this period.
Unlike many leading causes of death and disability, COPD
is projected to increase all over the world as smoking habits
rise in many countries and the population ages. In this paper,
COPD is considered to illustrate one of the many envisaged
use cases of the MoSHCA project.
Another chronic disease that is increasing in prevalence
in many countries, in particular in the Western World, is
diabetes mellitus type 2 - a metabolic disease that now affects
hundreds of millions of people, often obese, around the world.
It is closely associated with cardiovascular diseases, such as
myocardial infarction and stroke, and it is the origin of reduced
function and disability due to its impact on the neural, renal
and visual systems, all of which are affected in the course of
time.
An emerging solution to alleviate this burden is to empower
patients with self-management technology; there is increasing
consensus among health care professionals and patients alike
that many chronic disorders can be better managed in the
home environment than in an outpatient clinic or hospital. Self-
management may involve taking self-measurements, behavior
change encouragement, such as taking regular exercise, weight
control and adopting a suitable diet. Adopting and maintaining
such behavior is not easy, and strategies which assist the indi-
vidual to change his behavior are welcome. Mobile technology
and intelligent medical applications may play an important role
in achieving this.
In this setting, MoSHCA’s research focuses on the devel-
opment of smart health care assistance, where smart refers to
the ability of drawing clinical conclusions about the patient’s
health status without, or with limited, human intervention.
Only by using intelligent self-management health care appli-
cations, it is possible to achieve sustainable, high-quality and
cost-effective care of chronic diseases. The MoSHCA project
will also create new business opportunities in mobile intelligent
multimedia health care assistance systems.
In this paper we introduce the principles and ideas that will
act as a foundation for the development of smart health care
assistants within MoSHCA.
II. MOTIVATION AND OBJECTIVES
In the last few years a shift took place from the traditional
computing and communication, using devices such as PCs and
laptops, to mobile devices such as smartphones and tablets.
Many medical mobile applications, also commonly called
apps, have recently emerged on the market, although without
an apparent strategy: often it is unclear in what way these
apps will contribute, e.g., to tackle the major threats to the
sustainability of the health care systems of the developed
world, as mentioned above.
The MoSHCA project focuses on user-centered and inclu-
sive design, ensuring that the technology developed is usable,
accessible and ergonomic, and thereby it caters for the wide
spectrum of design needs of patient populations in particular,
and for the whole population in general. This is especially im-
portant in health applications where usability needs of people
with chronic diseases and disabilities, namely the elderly, are
paramount. MoSHCA’s vision is that, as the current pressure
on health care is mainly due to demographic changes in
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Fig. 1. MoSHCA value chain – stakeholders and expected benefits.
society, augmented by changes in the people’s overall health, a
patient oriented approach to health care innovation is essential.
Building the system around its users will help bridging the
gap between the health care system and the citizens. One of
the main goals here is to provide a sustainable structure and
simplicity to the end-users/patients.
The overall innovation of MoSHCA is to develop consider-
able and measurable advances in intelligent health care system
solutions for patients with chronic diseases, and general health
monitoring solutions, by offering:
• user-friendly medical applications embedded in smart
computing and communication devices, such as smart-
phones and tablets, enhanced with sensor technolo-
gies;
• intelligent clinical decision support, taking into ac-
count the various parameters involved in the manage-
ment of chronic diseases;
• a better understanding of the issues involved to main-
tain privacy and security, and available solutions;
• increased context awareness of health care applica-
tions;
• improvement of the reliability of medical sensors, and
the reduction of its energy consumption;
• increased interoperability with information systems.
An overview of MoSHCA’s value chain is presented in Fig. 1.
III. RELATED WORK
From the mid-1990s onwards, when Internet access and
usage became widespread and turned into the primary network
for telecommunications, eHealth emerged as a promising field
for better and more efficient health care delivery using web-
enabled services. The subsequent eHealth revolution gave rise
to a substantial growth in the number of available tools to
monitor the patient’s condition, usually in the home environ-
ment, and in facilitating earlier diagnosis and more effective
treatment [4]. Examples of commercial systems employed in
practice include Bosch Health Buddy [5], [6] and Intel Health
Guide [7], which are devices that support the attachment of
sensors and the transmission of data to a central server where
they can be inspected by responsible caregivers.
Although existing eHealth systems support monitoring of
the patient’s condition, they provide very limited feedback to
the user. Typically, a few, often just one, clinical parameters
are measured, and stored within a database system to be
interpreted by a health care professional. Thus, these systems
just collect data and lack the clinical interpretation capabilities
of a medical doctor, who takes the patient’s history into
account, including that of the underlying disease, and has the
clinical expertise to interpret patient data.
The availability of modern mobile computing and com-
munication technologies opens new avenues for computing,
allowing a part of the medical decision-making tasks, such as
diagnosis, selection of appropriate treatment, and prognosis,
to be relocated from the doctor side to the patient, at any
place and at any time [8]. This technology has given rise to
the field of mobile health or mHealth [9]. Currently, the most
commonly used mHealth technologies include smartphones,
personal digital assistants (PDA), wireless tablet computers,
wearable wireless bio-sensors and disease monitoring devices.
The rapid penetration of this kind of devices into our daily
lives is expected to provide greater access to health care, to
larger segments of the population. Another great advantage of
mHealth lies in its capability to support patient empowerment
by helping improving the awareness on his/her own health
condition and on the estimated outcomes, guided by the
mentioned smart devices. Always with the explicit intention
of the user/patient.
IV. MOSHCA ARCHITECTURE
The MoSHCA general architecture is shown in Fig. 2.
Basically, it consists of devices that collect information directly
from the user or from databases that contain user data, typically
in electronic health records. The essence of a mHealth archi-
tecture is that the user obtains appropriate feedback from the
mobile device through the interpretation of available data. Such
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Fig. 2. MoSHCA general architecture.
feedback is provided by an embedded decision-support system.
The most important components of the MoSHCA architecture
are briefly described hereafter.
A. Mobile Computing Device and Sensors Interface
The MoSHCA user’s device is a stand alone mobile com-
puting and communication device, which supports collecting
information about symptoms and further aspects directly from
the patient, interpreting them and providing instant feedback
about the patient’s health status. In addition, the device
communicates the patient’s data to a web-center where a
caregiver can further examine the patient condition. A common
smartphone or tablet can act as the user device.
For COPD it is interesting to measure the lung function
and blood-oxygen levels to complement the recorded clinical
symptoms. Interfaces and devices relevant to the COPD use
case include (i) external sensors, such as micro-spirometer
and pulse-oximeter, and built-in sensors within the mobile
device, allowing measurements of the lung function and (ii)
a communication interface with external sensors based, for
example, on Bluetooth or Wi-Fi.
B. Decision Support Systems
1) Basic Principles: Decision support systems act as a
central component of the MoSHCA architecture, as they offer
the required intelligent interpretation of data obtained from
the user. How the knowledge is formally represented in a
decision support system will depend on how and for what the
knowledge is used. Knowledge representation principles range
from simple rules defined for alerting the user, e.g. when a
measurement exceeds the normal value of a parameter or when
required clinical data is missing, to more advanced methods
based on decision trees, flow charts, and Bayesian networks,
used for example diagnosis or recommending appropriate
treatment. The basic knowledge for the development of clinical
decision support systems comes from evidence-based clinical
guidelines, treatment protocols, research practices, and input
from clinical experts. In a COPD use case, models need to
interpret the information from sensors such as the micro-
spirometer and pulse-oximeter, in the context of the patient’s
history and clinical aspects.
Fig. 3. State modeling the development of a syndrome.
2) Probabilistic Methods: Given the cause-effect relation-
ships and the uncertainty inherent to the medical domain,
we use a special class of probabilistic graphical models –
Bayesian networks – as a technique for building clinical
decision models for smart health care assistants that need to be
able to interpret clinical data in the context of chronic disease.
A Bayesian network is an acyclic directed graph consisting
of vertices, representing random variables of interest, and
arcs, representing dependencies between variables [10]. Each
random variable has a quantitative part, denoting conditional
probabilities of the type P (Y |pa(Y )), that is the probability
that Y takes on a specific value given the values of its
parent variables pa(Y ) in the graph. Probabilities of interest
can be computed from the joint probability of all variables.
For example, in the case of COPD the probability of an
exacerbation given the evidence obtained from monitoring
is computed. An important observation is that although the
model describes general relations between the variables of
interest, all predictions are personalized by entering patient-
specific data and the model can provide ’what-if’-predictions
by entering virtual evidence. Bayesian network models can be
built manually using domain knowledge, learned from data or
constructed through a combination of both approaches.
An important advantage of Bayesian networks is that they
allow modeling of temporal processes, which are typical for
the medical domain. In a state model, the functioning of a
particular organ X at a specific moment t determines the
outcome of laboratory tests and the presence or absence of
symptoms. The set of associated symptoms and signs are
indicators for the dysfunction of one or more body organs
and can be distinguished as major and minor in establishing
the diagnosis of a disease, or syndrome, when there is no clear
pathophysiological substrate. The association between the syn-
drome and the conditions may also be explained by risk factors
such as existing diseases, age, gender, and genetics, which
affect the functioning of the organs related to the syndrome.
Apart from the risk factors, the intake of drugs also affects
the organ functioning, e.g., by reducing the progression of the
disease. The schematic representation of these relationships is
depicted in Fig. 3, where the arrows exemplify the cause-effect
direction.
3) Classifiers: Bayesian networks can be used as classi-
fiers, i.e. as functions that map the state of the patient to
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exactly one of a fixed set of categories. In a health care context,
the simplest possible classifier is one that would be able to
establish whether a particular condition is present or absent.
Probabilistic methods are known to be very suitable as a
foundation for building classifiers. Even the simple Bayesian
network known as ‘naive Bayes’, a Bayesian network with a
very restricted graph topology, is known to offer good, often
acceptable, classification performance in many cases. In addi-
tion to probabilistic methods, further methods are explored to
allow identifying particular patterns in data, such as in sound.
In particular, neural networks and support-vector machines are
state-of-the-art methods for building these classifiers.
4) Case-based Reasoning: While the above-mentioned
methods interpret data from the user by means of models
built from previously collected data or from expert knowledge,
case-based reasoning takes a completely different approach: it
interprets data by comparing a case to previous cases, selecting
those that match the current case the best, as an explanation.
Case-based reasoning is suitable when one has little or no
interest in understanding a solution in terms of a model.
C. Electronic Health Records
Any form of clinical health assessment is based on knowl-
edge about the history of the patient’s illness. Electronic health
records, as available in hospitals and general practice, contain
such information. Exploitation of such historic information
would be very valuable for initializing a decision-support
systems in such a way that it would be able to effectively
manage the progression of a disease. However, access to
electronic health records is hampered by technical issues –
mostly the free text format of clinically relevant data – together
with privacy and security issues.
V. COPD USE CASE AND MOSHCA’S FRAMEWORK
The MoSHCA framework will be applied to various use
cases, which include Rehabilitation Technology After Stroke,
Treatment Advice for Diabetics, Dietary Advice for Prevention
of Lifestyle-related Diseases, Early Detection of Epileptic
Seizures, Monitoring of Premature Babies, and Monitoring
of Hypertensive Patients. To illustrate MoSHCA’s architecture
and technology, another considered use case – Disease Man-
agement of Patients with COPD – is described here in more
detail.
Chronic obstructive pulmonary disease (COPD) is esti-
mated to affect about 64 million people worldwide and is one
of the major chronic diseases in terms of both morbidity and
mortality. COPD is a lung disease affecting the respiratory
system, decreasing lung capacity and obstructing airways, thus
interfering with normal breathing. This results in reducing
patient’s capability of performing day-to-day activities. The
main cause of COPD is prolonged exposure to tobacco smoke,
but other causes include severe air pollution as well. COPD
is currently not curable, but treatment can reduce the effects
considerably.
The pathophysiology of the patient’s respiratory system is
assessed via symptoms such as dyspnea (shortness of breath),
productive cough, wheezing breath and decreased activity due
to dyspnea. Besides these symptoms a number of physiological
signs are relevant, in particular the forced expiratory volume in
1 second (FEV1) and blood oxygen saturation. FEV1 measures
airway obstruction by testing to what extend the patient can
overcome obstructive and restrictive resistance during forced
exhalation. A number of other indicators of deterioration exist,
like blood oxygen pressure and white blood-cell counts, but
measuring them requires hospital-grade equipment and incurs
considerable inconvenience for the patient.
An important aspect of COPD which is particularly relevant
in the present context is the progressive nature of the disease.
Specifically exacerbations – acute events of worsening of the
COPD-related health status – are important events in the pro-
gression of COPD and have a profound impact on the patient’s
well-being and on health care costs. These exacerbations are
mainly caused by airway infections, resulting in symptom
worsening. Also important to note is that patients with frequent
exacerbations usually have faster disease progression, which
makes exacerbation prevention a particularly relevant goal.
Additionally, a faster treatment response to exacerbations leads
to better recovery. Due to the limited observability it is not yet
possible to give a practical definition of exacerbations in terms
of pathophysiology. Hence, exacerbations are usually defined
as an increase in symptom appearance, use of medication, or
unscheduled health care use.
Monitoring patients in a home setting, as supported by the
MoSHCA framework and devices, can offer a cheaper, yet
reliable solution to detecting and managing the occurrence of
exacerbations of COPD at an early stage. We aim to decrease
the impact of COPD on the patient’s quality of life, and
avoid unscheduled doctor visits and hospitalization due to
exacerbations.
VI. EVALUATION
The usability and reliability of mobile health systems are
key factors in their acceptance and adoption for long-term use,
by the users, in disease self-management. To guarantee these
properties, a thorough evaluation of each system’s components
(hardware and software) is required, which involves multiple
testing phases. This process usually starts by testing the indi-
vidual components (for example, use of sensors, mobile device
operation, manual data entry), then moves on to integrated
testing to check whether or not the different components
work together as intended (for example, data transmission,
networking), and finally by performing field tests with the
users in the environment for which the system was actually
designed. During the first two phases, formal methods, such
as model checking and program verification, may be applied,
for example to prove the absence of deadlocks. During field
testing, evaluation is done by a randomized clinical trial,
where each patient is using the same system, but for half
of the randomly selected patients the system will have no
effect on the management of the disease, in such a way that
the system does not provide any effective feedback to those
patients, while for the other half of the patients the system will
indeed give such appropriate feedback. As for many mobile
health systems guarantees can be given that they will never
be harmful to the patient, evaluation amounts to determine
whether the originated intervention is effective, i.e. that it
contributes to improve health care by comparing standard care
results, such as the number of patients that are admitted to a
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hospital each year. If the number of admissions has dropped for
patients who used the mobile health system, then there would
be clear evidence that the system would have been effective.
Before an actual field test can be started, insights are
needed regarding the usability, reliability, and user-friendliness
of the system, because, if the system fails to meet reasonable
requirements regarding these aspects, carrying out a proper
field test will be a clear waste of time. Therefore, before any
field testing is carried out, in the MoSHCA project, usability
tests will be performed with future users, subsequently obtain-
ing feedback through questionnaire. The feedback will not only
report on issues with the technical operation of the system, but
it will also relate to usefulness and added value in terms of
self-management, confidence, and willingness for a continuous
usage of the system. A usability test may also help pinpoint
issues that need to be worked on to improve the system.
VII. CHALLENGES
A. Hardware Limitations
Although current mobile devices such as smartphones have
sufficient processing power for off-line data interpretation and
signal processing, continuous and real-time interpretation of
user data will inevitably put high demands on available battery
power. There is a need for more insight in the trade-off between
available battery power and apps algorithms execution, in
association with energy consumption.
B. Communication
The concept of a smart health care assistant implies the
need for deploying different sensors depending on the diseases
which are dealt with. However, we are not yet in the position
that one can easily integrate a new/unforeseen sensor in
the smart health care assistant’s architecture. Often, the data
exchange protocol of a commercially available sensor is not
publicly available and/or a generic interface device that allows
integrating different sensors does not yet exist.
C. Model Building
Building disease models for the interpretation of user data
from scratch is difficult and time consuming. However, after
the introduction of a smart health care assistant it may become
feasible to exploit machine-learning methods to learn and tune
models from large sets of user data, giving rise to a gradual
quality improvement of the device. However, until the wide-
spread availability of these devices, manual building of models
will be primarily practice.
D. Contextual Awareness
Patient characteristics, such as age, gender, personal and
family history of diseases, lifestyle choices with respect to
eating, alcohol consumption, smoking and sports, are often
the factors that affect the risk of developing a disease. When
a disease is already present, these factors and related options
may, positively or negatively, affect the course of the disease.
Such patient-specific information can be easily collected by
answering questions or filling-out questionnaires on a mobile
device. Part of this information is also available in health
records. It will be a key challenge to integrate all this con-
textual information in order to provide robust and relevant
feedback to the user.
E. Ethical Considerations and Safety
Current concerns for establishing the public’s trust in mo-
bile health systems relate to the security of collecting and trans-
mitting patient data. However, these concerns are expected to
be outweighed in the future by further developments in digital
security using, for example, electronic signatures, authentica-
tion and multi-application smart-card solutions, and by proven
health benefits to the individual by using mHealth systems.
Furthermore, a mobile health system can in principle function
without access to remote data, so future developments may
allow the patient to control whether or not its sensitive data
is transmitted, and when. Also, appropriate training programs
can further enhance the willingness of health care professionals
to adapt their clinical practices by using mobile decision-
support technologies. Finally, mHealth systems are meant to
stimulate sharing the responsibility between all stakeholders in
the health care system, which in turn can stimulate further the
development of the involved technologies.
VIII. CONCLUSION
The development of smart mobile health care assistants
involves various research challenges, many of them technical,
while others concentrate on the stakeholders, such as the end-
user and society as a whole. In the MoSHCA project these
challenges are addressed by well-chosen use cases that cover a
wide range of current and future applications of smart mobile
technology. This paper covers the main issues that must be
tackled for the successful development and deployment of such
systems.
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